Compare MRM & AMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRM | AMS |
|---|---|---|
| Founded | 2000 | 1980 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.8M | 13.8M |
| IPO Year | 2020 | N/A |
| Metric | MRM | AMS |
|---|---|---|
| Price | $2.05 | $2.11 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 88.8K | 10.4K |
| Earning Date | 05-22-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $55,915,220.00 | $29,423,000.00 |
| Revenue This Year | N/A | $3.81 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $51.31 | ★ N/A |
| Revenue Growth | 12.79 | ★ 17.84 |
| 52 Week Low | $0.34 | $2.01 |
| 52 Week High | $4.45 | $3.59 |
| Indicator | MRM | AMS |
|---|---|---|
| Relative Strength Index (RSI) | 46.23 | 48.55 |
| Support Level | $2.02 | $2.03 |
| Resistance Level | $2.33 | $2.16 |
| Average True Range (ATR) | 0.09 | 0.06 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 22.22 | 42.07 |
MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.